E.mbrace – Vaccine for prevention of blood infection caused by E.coli (Click here to learn more)

The purpose of this clinical research study is to assess the efficacy and safety of an investigational vaccine in the prevention of a blood infection caused by E. coli bacteria.

You may be eligible to participate in this study if you:

  • Are 60 years of age or older
  • Have had a UTI in the past 2 years
  • Feel comfortable, or have a caregiver who is comfortable, using an application on a smartphone

If eligible, you will be in the study for approximately 3 years. You will complete a minimum of 8 study visits, some in person and some remote via telephone.

You will be randomly assigned to one of the two study groups. This means you may receive either a placebo (contains no active medication) or the investigational vaccine. Neither you nor the study team will know which study group you are in.

The investigational vaccine or placebo will be given via a single injection on Day 1 of the study.

Qualified participants may receive the investigational vaccine or placebo and some study-required medical care at no cost.

For more information about this study, please call 316-425-6333.